Non-Statin Therapies for LDL-C Lowering; How to Rationally Use Them

Practical Insights of Cholesterol Guidelines for Secondary Prevention of ASCVDПодробнее

Approaches to Lowering LDL-C. What is new in 2021 for Statin Intolerant Patient?Подробнее

The 2022 ACC Expert Consensus on the Role of Nonstatin Therapies: An Expert-Guided TourПодробнее

LDL-C as a Path to Reducing Cardiovascular EventsПодробнее

Non Statin medications for cholesterol lowering? #statin #cholesterolПодробнее

Optimizing LDL-C Lowering With PCSK9 InhibitionПодробнее

How to Integrate NON-Statin Therapy in Your PracticeПодробнее

New Nonstatin Cholesterol Lowering Drugs: How to Use ThemПодробнее

The Role of Non-Statin Therapies in Optimal Cholesterol ManagementПодробнее

New Guidelines in DyslipidemiaПодробнее

Dr Erin Bohula May - 'At the limits of lipid management – statins to PCSK9 inhibitors'Подробнее

ACC Provides Guidance on Non-Statin TherapiesПодробнее

LDL- C lowering by statins & CVD reduction Any linkПодробнее

The Importance of Lowering LDL-C Early in LifeПодробнее

Upcoming webinar: The role of non-statin therapy in the management of dyslipidemiaПодробнее

Novel Therapeutic Strategies Targeting PCSK9 for Reducing LDL-C in Hyperlipidemia and ASCVDПодробнее

Watch Before You Take a Statin for High Total or LDL CholesterolПодробнее

Treatment Strategies for Drug-Resistant Hyperlipidemia, Part 2Подробнее

Additional insights on The Spectrum of LDL C Lowering Therapies and Efficacy in WomenПодробнее